120 related articles for article (PubMed ID: 9184185)
1. Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma.
Rasmuson T; Grankvist K; Ljungberg B
Br J Cancer; 1997; 75(11):1674-7. PubMed ID: 9184185
[TBL] [Abstract][Full Text] [Related]
2. Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma.
Rasmuson T; Grankvist K; Jacobsen J; Ljungberg B
Eur J Cancer; 2001 Nov; 37(17):2199-203. PubMed ID: 11677107
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Papworth K; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
[TBL] [Abstract][Full Text] [Related]
4. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma.
Ljungberg B; Grankvist K; Rasmuson T
Eur J Cancer; 1997 Oct; 33(11):1794-8. PubMed ID: 9470835
[TBL] [Abstract][Full Text] [Related]
6. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
[TBL] [Abstract][Full Text] [Related]
7. Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma.
Rasmuson T; Grankvist K; Ljungberg B
Acta Oncol; 1996; 35(4):479-82. PubMed ID: 8695165
[TBL] [Abstract][Full Text] [Related]
8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
9. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
Hamidi N; Gökçe MI; Süer E; Baltaci S
Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
[TBL] [Abstract][Full Text] [Related]
11. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract][Full Text] [Related]
13. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of serum calcium level with tumor size and stage of renal cell carcinoma].
Bai H; Zheng SB; Wu J; Liu DZ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1435-7. PubMed ID: 16305975
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
Jacobsen J; Rasmuson T; Grankvist K; Ljungberg B
J Urol; 2000 Jan; 163(1):343-7. PubMed ID: 10604387
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.
Kimura M; Tomita Y; Imai T; Saito T; Katagiri A; Tanikawa T; Takeda M; Takahashi K
Br J Cancer; 1999 Jul; 80(10):1648-51. PubMed ID: 10408413
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden.
Grabowska B; Ulvskog E; Carlsson J; Fiorentino M; Giunchi F; Lindblad P; Sundqvist P
Scand J Urol; 2018 Jun; 52(3):206-212. PubMed ID: 29972347
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
20. Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma.
Rasmuson T; Ljungberg B; Grankvist K; Jacobsen J; Olsson T
Acta Oncol; 2001; 40(1):83-7. PubMed ID: 11321667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]